Adrenal Bone Cardiovascular Diabetes Endocrine-Disrupting Chemicals Endocrine-Related Cancer Metabolism Neuroendocrinology Obesity Reproduction Steroid and Steroidogenesis Thyroid
Recommendations for the initial clinical assessment, investigation and genetic testing of children with growth failure and/or short stature
New BSPED paediatric adrenal insufficiency consensus guidelines
Opportunities to get involved – current committee vacancies
Welcome to BSPED’s new Treasurer-elect
Nominations now open – James M Tanner Award 2023
Children with type 1 diabetes and obesity are 50% more at risk of non-alcoholic fatty liver disease than non-obese children with type 1 diabetes, according to a study published in Journal of Diabetes and its Complications.
Research, published in JCI Insight, indicates that oestrogen receptor-positive breast cancer that has become endocrine resistant may be successfully treated by a new class of drugs currently undergoing clinical trials.
A Danish study, published in The Lancet Regional Health-Europe, has identified a strong association between a variant of the HNF1A gene and the risk type 2 diabetes in the Greenland Inuit population.
Data from a study published in Nature suggests that high-dose injections of Lac-Phe can reduce appetite, induce weight loss and improve glucose tolerance in obese mice.
Routine screening of adults for HbA1c would be beneficial for diagnosing type 2 diabetes and avoiding long-term complications, according to research published in Diabetologia.
Exposure to endocrine-disrupting chemicals, phthalates, can accelerate the growth uterine fibroids in vitro, according to data published in PNAS.
